
    
      This is a multi-center, open-enrollment, retrospective, non-interventional epidemiologic
      study without any clinical treatment. Its primary objective is to understand 1) incidence of
      drug-induced liver injury, including incidences among all the hospitalized patient, among
      patients in department of hepatic diseases, digestive diseases, oncology, hematology etc.,
      individually; 2) epidemiologic characteristics of drug-induced liver injury, including
      suspected medications, clinical types, histological characteristics, severity and outcomes.

      It investigates medical records of patients who were hospitalized during 2012 to 2014. Those
      patients should be diagnosed as drug-induced liver injury, drug-induced liver disease,
      drug-induced hepatitis, drug-induced hepatocirrhosis, drug-induced hepatic failure, or any
      other similar diagnosis of drug-induced liver injury nature.
    
  